225ac-psma-617
novartis
['prostate', '225ac']
from #aacr23: presented phase 1 #clinicaltrial results from a study evaluating 225ac-j591 for metastatic castration resistant #prostatecancer. (cc: ) 
The Weill Cornell Medicine (WCM) Genitourinary (GU) Oncology Program provides cutting-edge care for people with prostate, kidney, bladder & testicular cancers.